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Eosinophilic esophagitis (EoE) is a relatively uncommon allergic disease. Presenting with variable gastrointestinal symptoms, the
deﬁnitive diagnosis is made after esophageal visualization and histological conﬁrmation of excessive esophageal eosinophils. The
scientiﬁc discovery of the pathophysiology of EoE has been aided by its relationship to other common and well-recognized allergic
diseases. Similarities and important diﬀerences have emerged to distinguish EoE as a signiﬁcant pediatric allergic disease with
unique medical care requirements.
1.Introduction
From an early description as a pathological sidebar in 1977
[1] eosinophilic esophagitis (EoE) has become an important
allergic disease. Currently, as a pediatric disease entity,
EoE requires the diagnostic acumen of multiple specialists,
including allergists, gastroenterologists, pathologists, and
radiologists. It presents with a spectrum of symptoms
depending on age and has a natural history of such short
duration that the prognosis for patients and their families is
diﬃcult to predict.
Eosinophilic esophagitis has the lowest prevalence in the
allergic disease family and ranked most to least common:
allergic rhinitis, asthma, atopic dermatitis, food allergy,
and EoE. Children with EoE often have other preexisting
allergic diseases, and, presumptively, young children with
EoE likely will develop other allergic disease(s) with age.
The pathophysiological understanding of the allergic disease
family has grown exponentially in the past decade, which is
equally true of EoE [2].
In this paper we will contrast and compare the known
pathophysiology and clinical circumstances of each of the
allergic diseases and EoE and suggest that EoE has disadvan-
tages to patients greater than or equal to its allergy family
members. An excellent consensus paper with recommenda-
tions for treating children and adults with EoE has been
recently published [3].
2.FoodAllergy versusEosinophilicEsophagitis
By every indicator IgE-mediated food allergy has increased
in the past decade. In almost all cases, symptoms of IgE-
mediated food allergy are readily deﬁned and generally tem-
porally approximate to the food ingested, but not persistent
or chronic. The diagnosis is relatively straightforward, using
a clinical history supported by appropriate allergy skin tests
or speciﬁc IgE blood tests. As long as the inciting food is
avoided, symptoms are totally gone, and daily therapy is not
indicated. With the exception of peanuts and tree nuts, food
allergy generally resolves itself by late adolescence. The exact
reason for the clinical presence of an allergy to a speciﬁc
food(s) is still unknown, considering many children allergic
to a speciﬁc food(s) have concomitant speciﬁc food serum
IgE levels (or positive skin tests) to tolerated foods.
In EoE an associated food allergy has been shown to have
both pathophysiological and clinical relevance. In contrast
to IgE-mediated food allergy where the avoidance of the
allergenic food(s) is almost always clinically beneﬁcial, even
an elemental diet does not induce remission in all subjects
with EoE. And compared to conventional IgE-mediated food
allergy, deciding on the food protein avoidance regimen
in EoE involves both standard skin testing and in some
cases allergy patch testing [4]. The scant data on patch
testing suggests that the range of food protein “allergy”
in EoE far exceeds conventional IgE-mediated food allergy2 Journal of Allergy
mechanisms. Despite the information gained using these
techniques(skintestingandpatchtesting)insomesituations
complete food protein avoidance is necessary for eﬀective
control of symptoms [5]. And ﬁnally, in contrast to food
allergy, current evidence does not support the eventual
tolerance of allergic food(s) and the total resolution of
EoE [6]. Although morbidity with EoE is relatively high,
mortality,ascomparedtofoodallergy,hasnotbeenreported.
3.EosinophilicEsophagitis and
AtopicDermatitis
Atopic dermatitis (AD) pathophysiology is a complex in-
teraction of intrinsic dermal/epidermal dysfunction and
humoral (IgE) and cellular (T-cell) reactivity to the envi-
ronment. In particular, abnormal ﬁlaggrin protein(s) (an
epidermal component) has been linked to severe AD phe-
notypes [7], with a resultant loss of epidermal integrity,
thus allowing interaction between the external environment
and the heightened immune response. Recent research has
suggested a diminished ﬁlaggrin protein in EoE, resulting in
decreased esophageal barrier function [8].
Atopy is a common ﬁnding in pediatric atopic dermatitis
and EoE, although nonatopic forms of AD and EoE are not
uncommon. IgE-mediated sensitization to food protein(s)
is commonly enhanced in both disease conditions, and the
elimination of sensitized foods has been a cornerstone of
therapy in EoE and a frequent discussion point in AD.
Multiple studies investigating food avoidance as an eﬀective
therapy for AD have not been convincing, despite the fact
that IgE-mediated food sensitization is common in AD.
The clinical relevance of avoiding IgE-mediated sensi-
tized foods in AD patients is limited. Preceding the use of
patch testing in EoE for foods was a movement to isolate
clinically relevant food allergies in AD using a delayed
(48–72 hours) food response [9]. Although in limited use
currently, these strategies suggest a more complex immune
response to food protein than through a Type 1 immune
reaction in both EoE and AD. The limited studies of patch
testing in EoE suggest a stronger association with disease
activity and/or therapeutic responsiveness to certain food
protein, especially milk [10]. Also, food protein exposure in
AD has several pathways to sensitization, including contact,
airborne, and even transplacental or via breast milk, while in
EoE food protein exposure may be through a systemic route
with esophageal transmural migration, or possibly by direct
contact during food ingestion.
Environmental allergen sensitization is common to both
AD and EoE, but studies do not exist that compare rates of
environmental sensitization in children with a single disease
state (EoE or AD), or each disease at diﬀerent ages. It is
generally held that young AD patients eventually develop
environmental allergen sensitization and often second or
third allergic diagnoses, but similar studies showing the
development of other allergic diseases have not been done
with early onset EoE. Conventional allergy immunotherapy,
often issued in allergic rhinitis and allergic asthma, is not
commonly utilized for AD and has not been reported for
EoE.
The prognosis of AD in children is considered good,
with many children having resolution of active disease by
adolescence. The current longitudinal data for pediatric-
onset EoE from a single center was not optimistic for
improvement [6], strongly suggesting a persistent course,
possibly into adulthood.
4. Eosinophilic Esophagitisversus
AllergicRhinitis
Allergic rhinitis is a relatively straightforward and common
allergic disease which usually starts in childhood. The
exposure and sensitization to an airborne allergen is then
recentered to an intranasal allergy response on re-exposure.
Although not commonly emphasized, the late phase allergic
is largely responsible for chronicity of symptoms. Subepithe-
lialthickeningandremodelingareapparentlypresent,butdo
not usually receive the same consideration as do the same
processes in the lower airway.
Food allergens only extremely rarely are involved in
allergic rhinitis, although a corollary process, pollen-food
allergy syndrome, may occasionally coexist. Allergic rhinitis
therapy is directed by and enhanced with appropriate skin
testing, with good clinical correlation. Avoidance can be
helpful, topical therapy with intranasal corticosteroids is
often successful, and allergy immunotherapy is a mainstay.
Complications arising from allergic rhinitis are uncommon,
but life-long disease is common.
In comparison to allergic rhinitis, EoE is uncommon,
sometimes indolent, or under recognized, with only an
occasional association with seasonal worsening. Eosinophilic
esophagitis patients can have positive skin tests to both
seasonal and nonseasonal allergens, but clinical esophageal
symptomatology to environmental allergens, in comparison
to nasal symptoms as seen with allergic rhinitis, is less
obvious. Food allergy, both immediate and possibly non-IgE
mediated, is common to EoE, unlike allergic rhinitis.
Recent data strongly suggests a signiﬁcant role for
remodeling/ﬁbrosis in EoE [11] and even smooth muscle
hyperplasia and possibly hyperresponsiveness [12]. Therapy
for EoE often hinges on topical inhaled corticosteroids, but
avoidance of food allergens can be partially (or even near
totally) remissive. Immunotherapy for EoE has not been
studied to date, and, in large part, therapeutic regimens are
empiric, without the long time honored beneﬁt of placebo-
controlled trials required in new allergic rhinitis therapies.
Like allergic rhinitis, the pediatric EoE patient may have
long-lasting disease, although the opportunity for serious,
life-altering sequela is likely much higher in EoE.
5. Eosinophilic EsophagitisversusAsthma
The occasionally used term “asthma of the esophagus” places
EoE in the same realm of disease pathophysiology of the
frequently cited “most common chronic disease of children”
asthma if not so much for its frequency but to its impact
on morbidity. The rapidly advancing basic research studies
in EoE, with a several decades of asthma pathophysiology asJournal of Allergy 3
a guide, have quickly moved EoE into position of signiﬁcant
biological complexity.
Asthma has run a gamut of pathophysiological causes,
smooth muscle constriction, bronchial hyperresponsiveness,
eosinophilic inﬂammation, speciﬁc T-cell hyperactivity, and
extensive cytokine production, although many of the pro-
cesses currently recognized date to work by Slater in the
early 1800s and Osler by the turn of the century [13]. EoE
was ﬁrst described only 4 decades ago. Like asthma, EoE
has a hierarchy of recognized histological consequences, the
discovery of which has been compressed into a mere decade
of research.
Asthma in young children is usually associated with
nonallergic triggers, especially viral illnesses, while asthma
that continues into grade school and later-onset asthma
usually has allergic comorbidity. Food allergy is a frequent
comorbid process, but avoidance of food protein never
induces remission of active disease. Asthma is usually
associated with wheezing or recurrent cough and is usually
considered early after its onset. The presence of wheezing is
readily apparent to most parents and is a tell-tale symptom
forhealthcareproviders.Therapidresponsetobeta-agonists
in a clinical setting, or in a pulmonary function laboratory,
provides conﬁrmation of likelihood for asthma. Current
asthma guidelines provide a literature-supported, evidence-
based approach for medical and supportive management,
with advancing complexity for diﬃcult-to-manage patients.
Unfortunately, asthma has always maintained an imposing
morbidity among the allergic diseases, although the rate
of asthma deaths has decreased this decade. The natural
history of pediatric asthma supports a reasonable chance for
sustained remission, although ﬁxed airway ﬂow changes may
persist.
EoE has a spectrum of presentations in children, with a
diﬀerent face with advancing age of onset. No one symptom
clearly dominates, unlike the recurrence of wheezing or
chronic cough seen in asthma. The relative infrequency,
as compared to asthma, may delay the diagnosis. In some
situations, the presence of EoE is totally unknown until an
incidental ﬁnding on an endoscopy for an unrelated concern
or only after the retrieval of a stuck esophageal foreign body.
The incidence of “silent” EoE is unknown. In contrast the
medical literature has thousands of epidemiological studies,
using multiple methods of ascertainment, looking at “hid-
den”asthma.Unlikeasthma,thedeﬁnitivediagnosisrequires
an invasive procedure, with the subsequent initiation of
largely empirical medical and/or food protein avoidance
therapy(s). Any prescribed therapeutic intervention does not
generally allow for a certain response, or easily determined
beneﬁt, without a repeat endoscopy. A published report in
pediatric EoE patients followed for over one decade does not
supportareasonablechanceofremission[6].Mortalityfrom
eosinophilic esophagitis has not been reported, in contrast to
asthma, currently at over 3000 deaths per year.
6. Summary
Eosinophilic esophagitis certainly matches the biological
complexity of atopic dermatitis and asthma. Asthma, allergic
rhinitis, food allergy, and to a less extent atopic dermatitis,
have long recognized and/or easily undertaken medical
protocols, which are further supported by evidence-based
research. The long-term clinical impact of EoE is yet, largely,
unknown, but studies suggest extended chronicity, while the
other allergic diseases, especially atopic dermatitis and most
food allergies,have a very reasonablelikelihood of remission.
Subject to some debate, the incidence of EoE is likely
increasing, as are all other allergic diseases. The potential
for morbidity in EoE appears to be high, but without
current reports of mortality, unlike food allergy or asthma.
Overall, EoE is a complex allergic disease, with long-term
concerns,withminimalpediatricplacebo-controlledtrials[14,
15] to guide therapy, and no readily apparent method of
following clinical progress, except repeated invasive testing
procedures. Extensive information has been gained on its
pathophysiology, aided by years of sequential understanding
of the other allergic diseases.
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